Associated Papers
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.
Tan S et al.
Cancer, 2025
39876053 (PubMed )
Supplement: supplement_1.pdf
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel.
Kisistók J et al.
Melanoma Research, 2023
37294123 (PubMed )
Supplement: mr-33-364-s001.xlsx › Supplementary5_nonSNPVariants
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
37304756 (PubMed )
Supplement: zcad025_supplemental_files.zip › Supplementary_Table_2.xlsx › BVs
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F et al.
Cell Death and Differentiation, 2021
33257846 (PubMed )
Supplement: 41418_2020_672_MOESM1_ESM.pdf
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.
Momozawa Y et al.
Nature Communications, 2018
30287823 (PubMed )
Supplement: 41467_2018_6581_MOESM5_ESM.xlsx › SD2
Particular molecular and ultrastructural aspects in invasive mammary carcinoma.
Mihalcea CE et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie, 2015
p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.
Venneti S et al.
Journal of Neuropathology and Experimental Neurology, 2011
PINK1-Interacting Proteins: Proteomic Analysis of Overexpressed PINK1.
Rakovic A et al.
Parkinson's Disease, 2011
Analysis of TP53 gene and particular infrastructural alterations in invasive ductal mammary carcinoma.
Mihalcea CE et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie, 0
Select a paper to view details